Regulating Rheumatoid Arthritis

Recruiting

• Conditions: 10003816; 10023213; rheumatoid arthritis

• Registration Number: NL-OMON52768
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 125

Inclusion Criteria

• Age range: >18 years
• Diagnosed with Rheumatoid arthritis
• Use of one or several small molecule anti-rheumatic drugs. Combination with
biologicals is allowed.
• Blood from healthy controls is obtained via the *mini-donor dienst* of the
UMC Utrecht or purchased as buffy coats from Sanquin, and is anonymous, except
for the age and sex

Exclusion Criteria

None

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Novel insights into various aspects of faulty immune regulation in RA, as well<br /><br>as the prerequisites for the development, implementation, and immunological<br /><br>monitoring of immune regulation restoring therapies in RA patients.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>